Replies to post #369 on China Cord Blood Corp (CO)

[locksflooring]

Rodman & Renshaw terminates its China Cord Blood (NYSE: CO) coverage in a research report published today. Rodman & Renshaw's last rating for China Cord Blood was a Market Outperform / Speculative Risk rating and a $6 price target.
In the report, Rodman & Renshaw states, "Effective immediately, we are terminating coverage of China Cord Blood Corp (CCBC) to better distribute resources throughout our coverage universe."
Shares of China Cord Blood closed today at $3.55, up 1.45% from Thursday's market close.


Read more: http://www.benzinga.com/analyst-ratings/analyst-color/11/07/1794677/rodman-renshaw-terminates-china-cord-blood-coverage#ixzz1T3u9KfNt
Rodman & Renshaw Terminates China Cord Blood Coverage | Benzinga.com
www.benzinga.com
Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals...